OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Vaping and CBD: can new technology overcome old problems?	232
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	154
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	115
E-cigarette use in young adults and adolescents: not so safe?	113
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	87
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	82
Ablation for lung cancer: hot or cold intervention	76
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline	76
Lung development genes, adult lung function and cardiovascular comorbidities	73
Correction: British Thoracic Society Winter Meeting 2023	65
Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study	60
Complex coexistence of COPD and cardiovascular disease	60
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	59
Ultrafine particles and health: the next frontier in understanding air pollution hazards	57
What constitutes meaningful gain in skeletal muscle strength in COPD?	57
Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease	57
Upstaging of screen-detected lung cancers during diagnostic assessment	56
At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation	52
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	50
Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial	50
British Thoracic Society Guideline for pleural disease	41
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	41
Toxic metals and lung health: silent poisons?	40
Beyond detection: what happens after lung cancer screening matters more	39
Muscle memory: genetic factors underlying functional impairment in COPD	39

Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	39
Ageing and ivacaftor: unravelling the long-term effects	38
Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study	37
Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review	36
Activation of epithelial and inflammatory pathways in adolescent elite athletes exposed to intense exercise and air pollution	36
Lung function as independent predictor of cardiovascular disease risk: implications for practice and policy	34
Tool in lesion verification of shape-sensing robotic-assisted bronchoscopy with cone beam CT in sampling peripheral pulmonary nodules	34
COPD in Africa: risk factors, hospitalisation, readmission and associated outcomes—a systematic review and meta-analysis	33